The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions

Nature Immunology

Volumn 9, Issue 9, 2008, Pages 1055-1064

  Kovalovsky, Damian ^a   Uche, Olisambu U ^b   Eladad, Sonia ^a   Hobbs, Robin M ^a,e   Yi, Woelsung ^a   Alonzo, Eric ^c   Chua, Kevin ^a   Eidson, Maggie ^d   Kim, Hye Jung ^a   Im, Jin S ^a   Pandolfi, Pier Paolo ^a,e   Sant'Angelo, Derek B ^a,b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Louis V Gerstner Jr Graduate School of Biomedical Sciences   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; PROMYELOCYTIC LEUKEMIA ZINC FINGER PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIVER; LYMPH NODE; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; INTERLEUKIN-4; KILLER CELLS, NATURAL; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 50049084627     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1641     Document Type: Article

References (62)

1. Petrie, H.T. & Zuniga-Pflucker, J.C. Zoned out: Functional mapping of stromal signaling microenvironments in the thymus. Annu. Rev. Immunol. 25, 649-679 (2007).
2. Rothenberg, E.V. & Anderson, M.K. Elements of transcription factor network design for T-lineage specification. Dev. Biol. 246, 29-44 (2002).
3. Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
4. Bendelac, A. & Medzhitov, R. Adjuvants of immunity: Harnessing innate immunity to promote adaptive immunity. J. Exp. Med. 195, F19-F23 (2002).
5. Kronenberg, M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annu. Rev. Immunol. 23, 877-900 (2005).
6. Matsuda, J.L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754 (2000).
7. Kronenberg, M. & Engel, I. On the road: Progress in finding the unique pathway of invariant NKT cell differentiation. Curr. Opin. Immunol. 19, 186-193 (2007).
8. Gadue, P., Morton, N. & Stein, P.L. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190 1189-1196 (1999).
9. Dao, T. et al. Development of CD1d-restricted NKT cells in the mouse thymus. Eur. J. Immunol. 34, 3542-3552 (2004).
10. Eberl, G., Lowin-Kropf, B. & MacDonald, H.R. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163, 4091-4094 (1999).
11. Veillette, A. Immune regulation by SLAM family receptors and SAP-related adaptors. Nat. Rev. Immunol. 6, 56-66 (2006).
12. Borowski, C. & Bendelac, A. Signaling for NKT cell development: The SAP-FynT connection. J. Exp. Med. 201, 833-836 (2005).
13. Chung, B., Aoukaty, A., Dutz, J., Terhorst, C. & Tan, R. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174, 3153-3157 (2005).
14. Pasquier, B. et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201, 695-701 (2005).
15. Egawa, T. et al. Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22, 705-716 (2005).
16. Kelly, K.F. & Daniel, J.M. POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol. 16, 578-587 (2006).
17. Dent, A.L., Shaffer, A.L., Yu, X., Allman, D. & Staudt, L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276, 589-592 (1997).
18. He, X. et al. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433 826-833 (2005).
19. Sun, G. et al. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat. Immunol. 6, 373-381 (2005).
20. Maeda, T. et al. Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF. Science 316, 860-866 (2007).
21. McConnell, M.J. & Licht, J.D. The PLZF gene of t(11;17)-associated APL. Curr. Top. Microbiol. Immunol. 313, 31-48 (2007).
22. Barna, M., Hawe, N., Niswander, L. & Pandolfi, P.P. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 25, 166-172 (2000).
23. Exley, M.A. et al. Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR α-chain CDR3 loop. Eur. J. Immunol. 38, 1756-1766 (2008).
24. Matsuda, J.L. & Gapin, L. Developmental program of mouse Vα14i NKT cells. Curr. Opin. Immunol. 17, 122-130 (2005).
25. Zelent, A., Guidez, F., Melnick, A., Waxman, S. & Licht, J.D. Translocations of the RARα gene in acute promyelocytic leukemia. Oncogene 20, 7186-7203 (2001).
26. Koken, M.H. et al. Leukemia-associated retinoic acid receptor α fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc. Natl. Acad. Sci. USA 94, 10255-10260 (1997).
27. Townsend, M.J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20, 477-494 (2004).
28. Costoya, J.A. et al. Essential role of Plzf in maintenance of spermatogonial stem cells. Nat. Genet. 36, 653-659 (2004).
29. Pellicci, D.G. et al. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. J. Immunol. 175, 4416-4425 (2005).
30. Mendiratta, S.K. et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6, 469-477 (1997).
31. Davis, M.M. & Bjorkman, P.J. T-cell antigen receptor genes and T-cell recognition. Nature 334, 395-402 (1988).
32. Benlagha, K., Wei, D.G., Veiga, J., Teyton, L. & Bendelac, A. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202, 485-492 (2005).
33. Gapin, L., Matsuda, J.L., Surh, C.D. & Kronenberg, M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2, 971-978 (2001).
34. Gumperz, J.E., Miyake, S., Yamamura, T. & Brenner, M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636 (2002).
35. Hammond, K.J. et al. NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 29, 3768-3781 (1999)
36. Stetson, D.B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069-1076 (2003).
37. Benlagha, K., Kyin, T., Beavis, A., Teyton, L. & Bendelac, A. A thymic precursor to the NK T cell lineage. Science 296, 553-555 (2002).
38. Falk, I., Potocnik, A.J., Barthlott, T., Levelt, C.N. & Eichmann, K. Immature T cells in peripheral lymphoid organs of recombinase-activating gene-1/-2-deficient mice. Thymus dependence and responsiveness to anti-CD3 epsilon antibody. J. Immunol. 156, 1362-1368 (1996).
39. + CD1d-dependent precursor stage. J. Exp. Med. 195, 835-844 (2002).
40. Nichols, K.E. et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11, 340-345 (2005).
41. Griewank, K. et al. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27, 751-762 (2007).
42. Bezbradica, J.S. et al. Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Immunity 25, 487-497 (2006).
43. Felices, M. & Berg, L.J. The Tec kinases Itk and RIk regulate NKT cell maturation, cytokine production, and survival. J. Immunol. 180 3007-3018 (2008).
44. Au-Yeung, B.B. & Fowell, D.J. A key role for Itk in both IFN-γ and I L-4 production by NKT cells. J. Immunol. 179, 111-119 (2007).
45. + T cell lineages in mice deficient for the Tec kinases Itk and RIk. Immunity 25 93-104 (2006).
46. Horai, R. et al. Requirements for selection of conventional and innate T lymphocyte lineages. Immunity 27, 775-785 (2007).
47. + T cells with innate function selectively develop in the absence of active Itk. Eur. J. Immunol. 37, 2892-2899 (2007).
48. + T-cell development. Nat. Rev. Immunol. 7, 479-485 (2007).
49. + T cells have different requirements for active Itk for their development. J. Immunol. 180, 6544-6552 (2008).
50. Phan, R.T. & Dalla-Favera, R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432, 635-639 (2004).
51. Barna, M. et al. Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev. Cell 3, 499-510 (2002).
52. Filipponi, D. et al. Repression of kit expression by Plzf in germ cells. Mol. Cell. Biol. 27, 6770-6781 (2007).
53. Shiraishi, K. et al. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression. Oncogene 26, 339-348 (2007).
54. Quaranta, M.T. et al. PLZF-mediated control on VLA-4 expression in normal and leukemic myeloid cells. Oncogene 25, 399-408 (2006).
55. McConnell, M.J. et al. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-Myc expression. Mol. Cell. Biol. 23, 9375-9388 (2003).
56. Parrado, A. et al. The promyelocytic leukemia zinc finger protein down-regulates apoptosrs and expression of the proapoptatic BID protein in lymphocytes. Proc. Natl. Acad. Sci. USA 101, 1898-1903 (2004).
57. Szabo, S.J. et al. A novel transictiption factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 (2000).
58. + T helper cells. Cell 126, 1121-1133 (2006).
59. Kronenberg, M. & Rudensky, A. Regulation of immunity by self-reactive T cells. Nature 435, 598-604 (2005).
60. Yu, K.O. et al. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand α-galactosylceramide bound to mouse CD1d. J. Immunol. Methods 323, 11-23 (2007).
61. Liu, Y. et al. A modified α-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 312, 34-39 (2006).
62. Lamb, T.J., Graham, A.L. & Petrie, A. T testing the immune system. Immunity 28, 288-292 (2008).